Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_assertion description "[Several TL-related single nucleotide polymorphisms had modest association with breast cancer risk overall, including TEP1 rs93886 (OR 0.82, 95% CI 0.70,0.95); TERF2 rs3785074 (OR 1.13, 95% CI 1.03,1.24); TERT rs4246742 (OR 0.85, 95% CI 0.77,0.93); TERT rs10069690 (OR 1.13, 95% CI 1.03,1.24); TERT rs2242652 (OR 1.51, 95% CI 1.11,2.04); and TNKS rs6990300 (OR 0.89, 95% CI 0.81,0.97).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_assertion evidence source_evidence_literature NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_assertion SIO_000772 23629941 NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_assertion wasDerivedFrom befree-20140225 NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_assertion wasGeneratedBy ECO_0000203 NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP643431.RAv6--KCvyi9LySOcHlKYDQka7RNL0tr3NJkCi8SRFCVY130_provenance.